Grants for Small businesses - Health

This funding opportunity is designed to support small businesses in developing innovative technologies that address social needs impacting substance use disorders, with a focus on improving access to care and reducing barriers for at-risk individuals.

This funding opportunity provides financial support for under-resourced U.S. institutions to acquire advanced scientific instruments that enhance biomedical research and education, particularly for students from diverse and underserved backgrounds.

This funding opportunity supports research collaborations between academic institutions and community behavioral health organizations to improve outpatient mental health and substance use treatment through evidence-based practices.

This funding opportunity supports innovative research projects that aim to reduce health disparities and promote health equity in diverse populations across the United States.

This funding opportunity supports small research teams in developing innovative biomedical technologies that address critical health challenges and improve healthcare accessibility.

The NINDSintends to reissuePAR-23-027 to solicit applications for basic research projects on chemical warfare agents, toxic industrial chemicals, and pesticides that have primary or secondary effects on the nervous system. Chemical threats are toxic compounds that could be used in a terrorist attack or accidentally released from industrial production, storage, or shipping. Projects supported by this NOFO are expected to generate data that elucidate mechanisms of toxicity of these agents, possible new manifestations of toxic exposures, and potential new targets for therapeutic development. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Winter 2024 with an expected application due date in Spring 2024. This NOFO will utilize the R01 activity code. Details of the planned NOFO are provided below.

This funding opportunity provides financial support to small U.S.-based businesses for the development and validation of analytical methods to measure biomarkers related to neurological and neuromuscular disorders, with an emphasis on enhancing inclusivity and collaboration in research.

This funding opportunity supports innovative research projects aimed at improving workplace safety and health by addressing significant occupational hazards in various organizations across the United States.

This funding opportunity provides financial support to U.S.-based organizations for the late-stage development and dissemination of biomedical technologies that have shown laboratory feasibility, aiming to enhance their accessibility and usability in the research community.

The Black Equity & Excellence Fund, established by the Central New York Community Foundation, is dedicated to supporting community-based projects that foster self-sufficiency and enhance the physical and economic well-being of the Black community in Central New York. This initiative aligns with the Foundation's broader mission to strengthen race-related matters and promote social and educational growth within the community. By investing in projects that directly address the unique needs and challenges faced by Black residents, the fund aims to create a more equitable and thriving environment, reflecting the Foundation's strategic priority of community development and social justice. The primary beneficiaries of this grant program are organizations and projects that explicitly serve the Black community, particularly in Onondaga and Madison counties. The overarching impact goal is to improve the quality of life for Black individuals and families through various interventions. The program aims to empower the Black community by building upon existing capabilities and addressing systemic disparities. This is achieved by focusing on specific interest areas that have been identified as crucial for community advancement and well-being. The fund prioritizes projects within several key focus areas, including Black Creatives, Black Leadership + Advancement, Black LGBTQIA+, Black Mental Wellness, Black Legacy + Generational Wealth, Black Business, Black Maternal Health, Black Civic Engagement, Black Youth + Students, and Black Tech. These areas reflect the Foundation's theory of change, which posits that targeted investments in these sectors will lead to holistic development and greater equity. Projects are encouraged to contribute to dialogue that strengthens race-related matters and supports social and educational growth, indicating a strategic approach to fostering long-term, sustainable change. Expected outcomes include increased self-sufficiency, improved physical and economic conditions, and enhanced community well-being within the Black community. Measurable results are tied to the types of projects funded, with different funding levels supporting various initiatives, from grassroots efforts and pilot programs to the expansion of existing projects and large capital projects. The eligibility criteria, which mandate Black leadership in senior executive positions and at least 51% Black board membership, further ensure that the projects are community-led and responsive to the needs of the Black population, thereby maximizing impact and fostering authentic community empowerment.

The Douglas Community Fund offers competitive grants specifically aimed at supporting medical and other various needs within Douglas County. With its origins in funding a regional medical facility, the fund places a high priority on the medical needs of the community. Grants range from $2,000 to $10,000, with some reaching $15,000-$20,000. Applicants are notified of their status in late March to early April. This grant program does not support multiyear funding requests. Grant renewed every year. Grant annual opening/ closing deadline: December 1st to January 16th

The Second Chance Act (SCA) of 2007 (Public Law 110- 199), reauthorized by the First Step Act of 2018, provides a comprehensive response to assist in the transition individuals make from adult confinement facilities (e.g., jails, prisons, detention centers) to their communities so that the transition is successful and promotes public safety. With this solicitation, BJA seeks to fund up to one award to deliver training and technical assistance (TTA) to correctional institutions to improve justice and health outcomes for reentering individuals by leveraging financing mechanisms, including new and existing Medicaid and CHIP opportunities.

This Notice of Funding Opportunity (NOFO) invites applications from eligible small businesses to develop solutions for commercialization that can be used to enable regional clinician-to-clinician genomic medicine eConsult services. Specifically, we seek products, such as technologies or services, that will allow for the development and sustainment of eConsult services. Eligible United States small business concerns (SBCs) may submit Small Business Technology Transfer (STTR) Phase I, and Fast-Track grant applications. Small business applicants interested in submitting a Small Business Innovation Research (SBIR) grant application should submit to the related funding opportunity, PAR-24-106. SBIR and STTR are phased programs. The main objective in SBIR and STTR Phase I is to establish the technical merit and feasibility of the proposed research and development efforts. An SBIR and STTR Phase II continues the R&D efforts to advance the technology toward ultimate commercialization. At the conclusion of an SBIR/STTR Phase II, it is expected that the small business will fully commercialize their product or technology using non-SBIR/STTR funds (either federal or non-federal). Small businesses that are eligible to submit Phase II applications for projects that were supported with a Phase I SBIR or STTR award are expected to submit the regular Phase II application as a "Renewal" application based on the awarded Phase I SBIR or STTR project. Only one Phase II application may be awarded for a specific project supported by a Phase I award.

This funding opportunity provides financial support to nonprofit organizations, government entities, and select for-profits for programs addressing substance use disorders in West Virginia, focusing on areas such as foster care, youth prevention, recovery housing, and workforce development.

This funding opportunity supports independent researchers in studying the prevention, diagnosis, and treatment of diseases related to military toxic exposures, benefiting Service Members, Veterans, and their families.

This funding opportunity supports research projects that explore the basic mechanisms and effects of trained immunity in the innate immune system, targeting a wide range of institutions and researchers interested in immune responses and related diseases.

This funding opportunity provides financial support to organizations that create and manage equine therapy programs aimed at improving the well-being and quality of life for disabled veterans and members of the Armed Forces.

The National Cancer Institute (NCI) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for the RNA Modifications Driving Oncogenesis (RNAMoDO) Initiative. It aims to promote mechanistic research in the emerging area of RNA modifications that drive oncogenesis, with a focus on the central role of RNA modifications in translational reprogramming of cancer cells. RNA modifications have been recognized to exert a substantial impact on gene expression and function and their de-regulation has been linked to the cancer phenotype. In particular, recent insights point to a crucial role for mRNA, tRNA, and rRNA modifications in translational reprogramming during tumor initiation, progression, and adaptation to therapy. However, the molecular mechanisms underlying this reshaping of the translatome caused by dynamic changes in RNA modifications, and especially the interplay between different RNA modifications within and across RNA molecules during translation, are not understood and represent the focus of this initiative. Historically, the research community has largely pursued investigations of RNA modifications by studying single RNA species and modification types. However, elucidating how dysregulation of mRNA, tRNA, and rRNA modifications reprograms translation to drive oncogenesis is not likely feasible for any single research laboratory, but will require the combination of expertise in mRNA, tRNA and rRNA biology, translational regulation, and cancer research. To stimulate progress in this emerging field, the RNAMoDO program will support collaborative research projects, preferably using an MPI structure, on how modifications in mRNA, tRNA, and rRNA molecules can drive the oncogenic process through translational reprogramming. To be responsive to the NOFO, each project will also explore the impact of interactions between modifications residing on the same or different RNA molecules during translation. This Notice of Intent to Publish (NOITP) is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in the early Fall of 2024, with an expected application due date in November 2024. The NOFO will utilize the U01 mechanism for Research Project Cooperative Agreement (Clinical Trial Not Allowed). Potential applicants are encouraged to view the presentation of this initiative to the NCI Board of Scientific Advisors (BSA), available at: (https://videocast.nih.gov/watch=54423) beginning at 1 hour, 32 minutes, 52 seconds. Presentation slides are downloadable at https://deainfo.nci.nih.gov/advisory/bsa/0324/Maas.pdf.

This funding opportunity supports research partnerships between technology developers and academic researchers to optimize and evaluate digital mental health interventions, particularly for underserved populations.

This funding opportunity supports research projects aimed at developing safe and effective medications for treating substance use disorders, particularly for substances like cocaine, methamphetamine, and cannabis, and is open to a wide range of eligible institutions and organizations.